Stephane Boissel Insider Trading $SGMO SANGAMO THERAPEUTICS, INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Stephane Boissel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Stephane Boissel. Stephane Boissel is EVP, Corp. Strat. & Int. CFO in SANGAMO THERAPEUTICS, INC ($SGMO) and EVP, Corp. Strategy in SANGAMO THERAPEUTICS, INC ($SGMO) and EVP, Corporate Strategy in SANGAMO THERAPEUTICS, INC ($SGMO).

Over the past year Stephane Boissel has been an insider in 1 company. The total value of shares held by Stephane Boissel in this company amounts to $327,339.

Stephane Boissel EVP, Corp. Strategy, EVP, Corp. Strat. & Int. CFO, EVP, Corporate Strategy
SANGAMO THERAPEUTICS, INC
$ 327339 The total value of shares held by Stephane Boissel
Insider Rank

Stephane Boissel ranks 25,586 out of 350,000 insiders. Go to Insider Ranking to see more.

Stephane Boissel in SANGAMO THERAPEUTICS, INC

Trading Symbol: SGMO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Stephane Boissel: EVP, Corp. Strategy, EVP, Corp. Strat. & Int. CFO, EVP, Corporate Strategy
Holdings: 85,023 shares
Current Value: $327,339
Latest Transaction: Jul 31 2020
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 5x
Sell: 4x
Shares Bought: 113,451
Shares Sold: 43,335
Share Difference: +70,116
Value Difference: +$476,091

Latest Insider Trading Transactions of Stephane Boissel in SANGAMO THERAPEUTICS, INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0002345
Value of Purchases ($)0000000
No. of Sales0002344
Value of Sales ($)000334,811351,022476,091476,091

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jul 31 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseE0.00101
Jul 31 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseE0.00102
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseM2.09122
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategySellD11.2314,907167,40670,11685 K to 70.1 K (-17.53 %)
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyBuyM0.0014,907085,02370.1 K to 85 K (+21.26 %)
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseM2.09122
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategySellD11.2314,907167,40670,11685 K to 70.1 K (-17.53 %)
Jun 05 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyBuyM0.0014,907085,02370.1 K to 85 K (+21.26 %)
Feb 26 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyOption ExerciseA6.80110,000748,000110,000
Feb 26 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyGrantA0.0055,000070,11615.1 K to 70.1 K (+363.85 %)
Feb 26 2020SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. StrategyPayment of ExerciseF6.802,38416,21115,11617.5 K to 15.1 K (-13.62 %)
Aug 14 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. Strat. & ...Option ExerciseM2.37123
Aug 14 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. Strat. & ...SellD11.2311,137125,06917,50028.6 K to 17.5 K (-38.89 %)
Aug 14 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. Strat. & ...BuyM0.0011,137028,63717.5 K to 28.6 K (+63.64 %)
Aug 14 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. Strat. & ...Option ExerciseJ0.00404
Aug 14 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corp. Strat. & ...Option ExerciseJ0.00404
Feb 27 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corporate Stra ...Option ExerciseA9.03105,000948,150105,000
Feb 27 2019SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corporate Stra ...GrantA0.0017,500017,5000 to 17.5 K
Nov 26 2018SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corporate Stra ...Option ExerciseA11.08283,5233,141,435283,523
Nov 26 2018SGMOSANGAMO THERAPEUTI ...Boissel StephaneEVP, Corporate Stra ...Option ExerciseA11.08283,5233,141,435283,523

Page:   1